Description
A mycotoxin with broad spectrum antibiotic activity against Gram positive and Gram negative bacteria; acted synergistically at 4-16 mg/L in vitro with erythromycin (500-2,000 mg/L) against multi-drug resistant strains of S. aureus; reduced tumor growth and prolonged survival synergistically with cyclophosphamide (20 mg/kg/d) in a mouse model of sarcoma
Formal name: (4α,6β,8α,9β,13α,14β,16β,17Z)-6,16-bis(acetyloxy)-3,7-dioxo-29-nordammara-1,17(20),24-trien-21-oic acid
Synonyms: BRN 3230584|Fumigacin|NSC 319943
Molecular weight: 568.7
CAS: 29400-42-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Toxins|Mycotoxins||Research Area|Cancer||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|MRSA